For comparison, Kilgore et al. recently reported that MET and BUF inhibited the viability of two endometrial cancer cells (ECC-1 and Ishikawa cell lines) with IC50 of 1.6 and 1.4 mM for MET and IC50 of 0.15 and 0.08 mM for BUF. The gene discussed is MET; the disease is endometrial cancer.